$MPAD
MICROPAC INDUSTRIES INC Stock $mpad

$mpad Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121465923013293 Filed on October 10, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$10.55M	$6.458M	$6.940M
YoY Change	38.95%	-6.95%	-15.16%
Cost Of Revenue	$6.656M	$4.576M	$3.667M
YoY Change	55.33%	24.79%	-16.79%
Gross Profit	$3.892M	$1.882M	$3.273M
YoY Change	17.73%	-42.5%	-13.25%
Gross Profit Margin	36.9%	29.14%	47.16%
Selling, General & Admin	$2.272M	$2.017M	$2.231M
YoY Change	20.53%	-9.59%	35.29%
% of Gross Profit	58.38%	107.17%	68.16%
Research & Development	$493.0K	$454.0K	$568.0K
YoY Change	-24.96%	-20.07%	11.37%
% of Gross Profit	12.67%	24.12%	17.35%
Depreciation & Amortization	$275.0K	$274.0K	$100.0K
YoY Change	183.51%	174.0%	7.53%
% of Gross Profit	7.07%	14.56%	3.06%
Operating Expenses	$2.765M	$2.471M	$2.799M
YoY Change	8.77%	-11.72%	29.64%
Operating Profit	$1.127M	-$589.0K	$474.0K
YoY Change	47.51%	-224.26%	-70.63%
Interest Expense	$148.0K
YoY Change	5.71%
% of Operating Profit	13.13%
Other Income/Expense, Net	-$96.00K	$44.00K	$966.0K
YoY Change	-2020.0%	-95.45%	-560.0%
Pretax Income	$1.179M	-$545.0K	$1.440M
YoY Change	29.7%	-137.85%	2.56%
Income Tax	$176.0K	-$15.00K	$335.0K
% Of Pretax Income	14.93%		23.26%
Net Earnings	$1.003M	-$530.0K	$1.105M
YoY Change	37.96%	-147.96%	1.56%
Net Earnings / Revenue	9.51%	-8.21%	15.92%
Basic Earnings Per Share		-$0.21	$0.43
Diluted Earnings Per Share	$0.37	-$0.21	$428.6K
COMMON SHARES
Basic Shares Outstanding	2.578M shares	2.578M shares	2.578M shares
Diluted Shares Outstanding		2.578M shares	2.578M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.30M	$11.45M	$15.60M
YoY Change	-33.01%	-26.62%	8.53%
Cash & Equivalents	$10.30M	$11.45M	$15.60M
Short-Term Investments
Other Short-Term Assets	$487.0K	$408.0K	$729.0K
YoY Change	-13.65%	-44.03%	66.06%
Inventory	$11.48M	$12.12M	$9.569M
Prepaid Expenses
Receivables	$8.328M	$3.911M	$4.522M
Other Receivables	$139.0K	$1.010M	$920.0K
Total Short-Term Assets	$30.73M	$28.90M	$31.34M
YoY Change	-1.49%	-7.8%	12.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$24.10M	$24.34M	$21.65M
YoY Change	7.28%	12.41%	215.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$475.0K	$102.0K
YoY Change	452.33%
Total Long-Term Assets	$24.57M	$24.44M	$21.68M
YoY Change	8.91%	12.74%	215.3%
TOTAL ASSETS
Total Short-Term Assets	$30.73M	$28.90M	$31.34M
Total Long-Term Assets	$24.57M	$24.44M	$21.68M
Total Assets	$55.31M	$53.34M	$53.02M
YoY Change	2.87%	0.6%	52.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.491M	$1.225M	$1.472M
YoY Change	27.11%	-16.78%	-2.32%
Accrued Expenses	$1.738M	$1.471M	$1.544M
YoY Change	2.66%	-4.73%	11.24%
Deferred Revenue
YoY Change
Short-Term Debt	$432.0K	$429.0K	$0.00
YoY Change	92.86%
Long-Term Debt Due	$432.0K	$429.0K
YoY Change	92.86%
Total Short-Term Liabilities	$4.723M	$3.697M	$4.574M
YoY Change	6.59%	-19.17%	40.18%
LONG-TERM LIABILITIES
Long-Term Debt	$15.32M	$15.42M	$14.36M
YoY Change	5.37%	7.37%	20123.94%
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$15.32M	$15.42M	$14.36M
YoY Change	5.37%	7.37%	10305.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.723M	$3.697M	$4.574M
Total Long-Term Liabilities	$15.32M	$15.42M	$14.36M
Total Liabilities	$20.04M	$19.11M	$18.95M
YoY Change	5.66%	0.85%	457.28%
SHAREHOLDERS EQUITY
Retained Earnings	$35.23M	$34.22M
YoY Change	1.07%
Common Stock	$308.0K	$308.0K	$308.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.250M	$1.250M	$1.250M
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	$35.27M	$34.23M	$34.07M
YoY Change
Total Liabilities & Shareholders Equity	$55.31M	$53.34M	$53.02M
YoY Change	2.87%	0.6%	52.85%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	$1.003M	-$530.0K	$1.105M
YoY Change	37.96%	-147.96%	1.56%
Depreciation, Depletion And Amortization	$275.0K	$274.0K	$100.0K
YoY Change	183.51%	174.0%	7.53%
Cash From Operating Activities	-$985.0K	$119.0K	-$77.00K
YoY Change	-250.38%	-254.55%	-102.11%
INVESTING ACTIVITIES
Capital Expenditures	$54.00K	$125.0K	-$3.086M
YoY Change	-95.79%	-104.05%	28.96%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$54.00K	-$125.0K	-$3.086M
YoY Change	-95.79%	-95.95%	28.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-111.0K	-206.0K	2.746M
YoY Change	-127.75%	-107.5%	3767.61%
NET CHANGE
Cash From Operating Activities	-985.0K	119.0K	-77.00K
Cash From Investing Activities	-54.00K	-125.0K	-3.086M
Cash From Financing Activities	-111.0K	-206.0K	2.746M
Net Change In Cash	-1.150M	-212.0K	-417.0K
YoY Change	406.61%	-49.16%	-131.52%
FREE CASH FLOW
Cash From Operating Activities	-$985.0K	$119.0K	-$77.00K
Capital Expenditures	$54.00K	$125.0K	-$3.086M
Free Cash Flow	-$1.039M	-$6.000K	$3.009M
YoY Change	65.71%	-100.2%	-50.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000065759
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--11-30
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid
CY2022Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2023Q3	MPAD	Restricted Stock Units RestrictedStockUnits		shares
CY2022Q3	MPAD	Restricted Stock Units RestrictedStockUnits		shares
	MPAD	Restricted Stock Units RestrictedStockUnits		shares
	MPAD	Restricted Stock Units RestrictedStockUnits		shares
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-08-26
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-5109
	dei	Entity Registrant Name EntityRegistrantName	MICROPAC INDUSTRIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-1225149
	dei	Entity Address Address Line1 EntityAddressAddressLine1	905 E. Walnut
	dei	Entity Address City Or Town EntityAddressCityOrTown	Garland
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75040
	dei	City Area Code CityAreaCode	(972)
	dei	Local Phone Number LocalPhoneNumber	272-3571
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2578315	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11449000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15375000	usd
CY2023Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	3288000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3644000	usd
CY2023Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	1010000	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	920000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	623000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	408000	usd
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7198000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	6715000	usd
CY2023Q3	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	4921000	usd
CY2022Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	3573000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	12119000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10288000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	408000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	564000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	28897000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	31199000	usd
CY2023Q3	us-gaap	Land Land	1518000	usd
CY2022Q4	us-gaap	Land Land	1518000	usd
CY2023Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	21013000	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	498000	usd
CY2023Q3	us-gaap	Inventory Buildings And Improvements InventoryBuildingsAndImprovements	1126000	usd
CY2022Q4	us-gaap	Inventory Buildings And Improvements InventoryBuildingsAndImprovements	1126000	usd
CY2023Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2065000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1036000	usd
CY2023Q3	us-gaap	Flight Equipment Net FlightEquipmentNet	153000	usd
CY2022Q4	us-gaap	Flight Equipment Net FlightEquipmentNet	19415000	usd
CY2023Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	10173000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	9952000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36048000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33545000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11707000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11082000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24341000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22463000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14000	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	102000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	86000	usd
CY2023Q3	us-gaap	Assets Assets	53340000	usd
CY2022Q4	us-gaap	Assets Assets	53762000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1225000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1173000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	926000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1086000	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	560000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1192000	usd
CY2023Q3	MPAD	Property Taxes PropertyTaxes	521000	usd
CY2022Q4	MPAD	Property Taxes PropertyTaxes	560000	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	12000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	149000	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	429000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	224000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	24000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	47000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3697000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4431000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15417000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14535000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	19114000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18966000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3078315	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3078315	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2578315	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2578315	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	308000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	308000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	944000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	885000	usd
CY2023Q3	MPAD	Treasury Stocks Shares TreasuryStocksShares	500000	shares
CY2022Q4	MPAD	Treasury Stocks Shares TreasuryStocksShares	500000	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1250000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1250000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	34224000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	34853000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	34226000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34796000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53340000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53762000	usd
CY2023Q3	us-gaap	Revenues Revenues	6458000	usd
CY2022Q3	us-gaap	Revenues Revenues	6940000	usd
	us-gaap	Revenues Revenues	20091000	usd
	us-gaap	Revenues Revenues	20194000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	4576000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	3667000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	13098000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	11188000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	454000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	568000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1731000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1534000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2017000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2231000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5833000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5849000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	7047000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	6466000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	20662000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	18571000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-589000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	474000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-571000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1623000	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	44000	usd
CY2022Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	966000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	218000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	967000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-545000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1440000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-353000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2590000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	335000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	530000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-530000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1105000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-371000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2060000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.43
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578315	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578315	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578315	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578315	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578315	shares
	us-gaap	Net Income Loss NetIncomeLoss	-371000	usd
	us-gaap	Net Income Loss NetIncomeLoss	2060000	usd
	us-gaap	Depreciation Depreciation	650000	usd
	us-gaap	Depreciation Depreciation	297000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	59000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	38000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	14000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	40000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-265000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-443000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	215000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	309000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1831000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	884000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-157000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	387000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-632000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-103000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	29000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	328000	usd
	MPAD	Accrued Compensation AccruedCompensation	159000	usd
	MPAD	Accrued Compensation AccruedCompensation	189000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-138000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	224000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-14000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-40000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-47000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	65000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2211000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1549000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2506000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11931000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2506000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11931000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	258000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	258000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1222000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	10990000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	173000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	791000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10732000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3926000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	350000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15375000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15252000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11449000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15602000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	177000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	302000	usd
	us-gaap	Interest Paid Net InterestPaidNet	405000	usd
	us-gaap	Interest Paid Net InterestPaidNet	373000	usd
	MPAD	Accrued Additions Property Plant Equipment AccruedAdditionsPropertyPlantEquipment	22000	usd
	MPAD	Accrued Additions Property Plant Equipment AccruedAdditionsPropertyPlantEquipment	402000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	32267000	usd
CY2022Q1	us-gaap	Dividends Dividends	258000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	464000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	32473000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	491000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	32964000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	1105000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	34069000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34796000	usd
CY2023Q1	us-gaap	Dividends Dividends	258000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-56000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	34482000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	39000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	215000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	34736000	usd
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	20000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-530000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	34226000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578315	shares
	us-gaap	Revenues Revenues	20091000	usd
	us-gaap	Revenues Revenues	20194000	usd
	us-gaap	Revenues Revenues	20091000	usd
	us-gaap	Revenues Revenues	20194000	usd
CY2023Q3	MPAD	Domestic Direct DomesticDirect	4349000	usd
CY2023Q3	MPAD	Domestic Distrbution DomesticDistrbution	1845000	usd
CY2023Q3	MPAD	International Distribution InternationalDistribution	264000	usd
CY2023Q3	us-gaap	Revenues Revenues	6458000	usd
CY2022Q3	MPAD	Domestic Direct DomesticDirect	4156000	usd
CY2022Q3	MPAD	Domestic Distrbution DomesticDistrbution	2535000	usd
CY2022Q3	MPAD	International Distribution InternationalDistribution	249000	usd
CY2022Q3	us-gaap	Revenues Revenues	6940000	usd
	MPAD	Domestic Direct DomesticDirect	13065000	usd
	MPAD	Domestic Distrbution DomesticDistrbution	5965000	usd
	MPAD	International Distribution InternationalDistribution	1061000	usd
	us-gaap	Revenues Revenues	20091000	usd
	MPAD	Domestic Direct DomesticDirect	12511000	usd
	MPAD	Domestic Distrbution DomesticDistrbution	7110000	usd
	MPAD	International Distribution InternationalDistribution	573000	usd
	us-gaap	Revenues Revenues	20194000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578315	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578315	shares
CY2023Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	3288000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3644000	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	4974000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	623000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	408000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	603000	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	560000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	1192000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	1258000	usd
	MPAD	Deferred Revenue Recognized DeferredRevenueRecognized	642260	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	165000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	14000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	40000	usd
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0325	pure
CY2023Q3	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578315	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zYI2OXVDbutb" style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86E_zcNbMBpyXSdl">Use of Estimates</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
CY2023Q3	MPAD	Fair Value Financial Assets Liabilities Recurring Basis FairValueFinancialAssetsLiabilitiesRecurringBasis	0	usd
CY2022Q4	MPAD	Fair Value Financial Assets Liabilities Recurring Basis FairValueFinancialAssetsLiabilitiesRecurringBasis	0	usd
CY2023Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	0	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-04-23
CY2023Q3	us-gaap	Notes Payable NotesPayable	15987000	usd
CY2023Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	141000	usd
CY2023Q3	MPAD	Net Debt NetDebt	15846000	usd
CY2023Q3	us-gaap	Debt Current DebtCurrent	429000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15417000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	106000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	433000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	447000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	463000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	479000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	14059000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	15987000	usd
	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2022-12-07
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2023-01-11
	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2023-02-10
	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2021-12-07
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2022-01-11
	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2022-02-10
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	20000.00	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	59000.00	usd
CY2023Q3	MPAD	Stockbased Unvested Compensation Expense For First Year StockbasedUnvestedCompensationExpenseForFirstYear	20000	usd
CY2023Q3	MPAD	Stockbased Unvested Compensation Expense For Second Year StockbasedUnvestedCompensationExpenseForSecondYear	78000	usd
CY2023Q3	MPAD	Stockbased Unvested Compensation Expense For Third Year StockbasedUnvestedCompensationExpenseForThirdYear	78000	usd
CY2023Q3	MPAD	Stockbased Unvested Compensation Expense StockbasedUnvestedCompensationExpense	176000	usd

Files In Submission

Name	View Source	Status
0001214659-23-013293-index-headers.html	Edgar Link	pending
0001214659-23-013293-index.html	Edgar Link	pending
0001214659-23-013293.txt	Edgar Link	pending
0001214659-23-013293-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mpad-20230826.xsd	Edgar Link	pending
p10923410q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
mpad-20230826_cal.xml	Edgar Link	unprocessable
mpad-20230826_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mpad-20230826_def.xml	Edgar Link	unprocessable
mpad-20230826_pre.xml	Edgar Link	unprocessable
p10923410q_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MPAD
MICROPAC INDUSTRIES INC Stock $mpad

2023 Q4 Form 10-Q Financial Statement

#000121465923013293 Filed on October 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPAD MICROPAC INDUSTRIES INC Stock $mpad

2023 Q4 Form 10-Q Financial Statement

#000121465923013293 Filed on October 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPAD
MICROPAC INDUSTRIES INC Stock $mpad